Geometric Wealth Advisors Invests $297,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Geometric Wealth Advisors bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 500 shares of the biotechnology company’s stock, valued at approximately $297,000.

Several other large investors also recently made changes to their positions in the company. Asset Dedication LLC grew its stake in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after buying an additional 18 shares during the period. Bleakley Financial Group LLC grew its stake in shares of Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after buying an additional 20 shares during the period. Venturi Wealth Management LLC grew its stake in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after buying an additional 21 shares during the period. Insigneo Advisory Services LLC grew its stake in shares of Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after buying an additional 22 shares during the period. Finally, Menard Financial Group LLC boosted its stake in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $515.45 on Tuesday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $39.50 billion, a P/E ratio of 133.19, a P/E/G ratio of 5.17 and a beta of 1.12. The company’s 50 day moving average price is $597.64 and its two-hundred day moving average price is $531.62. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99.

Insider Buying and Selling

In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have issued reports on AXON shares. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, Robert W. Baird lifted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.